Circulating levels of ADAM12, a stromal activation biomarker, are predictive of survival in pancreatic ductal adenocarcinoma (PDAC)

Autor:	O.R.C. Busch, Helene Damhofer, V.L. Veenstra, Frederike Dijk, Johanna W. Wilmink, R. Jiang, M.G. Besselink, C. Waasdorp, Daniel W. Pierce, M.F. Bijlsma, L.B. van Rijssen, H.W.M. van Laarhoven, J. Shiansong Li, J.P. Medema
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty Stromal cell Pancreatic ductal adenocarcinoma business.industry Internal medicine ADAM12 Biomarker (medicine) Medicine Hematology business
Zdroj:	Annals of Oncology. 28:v254-v255
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx369.128
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0b53586345da3c144c49f7bffd0acf79 https://doi.org/10.1093/annonc/mdx369.128 Zobrazit plný text záznamu